Kenneth Buch, MD
Gastroenterology · Encino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 48 years
- Js Weill Medical College, Cornell University, 1978
Offices
1 location · Genesis Healthcare Partners PC · 232 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Buch’s office at (818) 989-1917 to ask if they take your plan before you enroll.
California Medical Board record
Licence G44883 · Current
Licensed to practise in California · since 1981 · expires 2028-09-30 · Cornell University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
- American Board of Internal Medicine - Internal Medicine
Original Medicare doctor bills
$189,699
Medicare paid this office $189,699 for 659 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 156 | $33,368 | $213 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 67 | $30,291 | $40 |
| Return visit (30+ min) | 236 | $26,109 | $99 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 67 | $22,115 | $52 |
| Short return visit (20+ min) | 190 | $17,081 | $70 |
See all 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 156 | $33,368 | $213 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 67 | $30,291 | $40 |
| Return visit (30+ min) | 236 | $26,109 | $99 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 67 | $22,115 | $52 |
| Short return visit (20+ min) | 190 | $17,081 | $70 |
| New patient visit (45+ min) | 103 | $12,268 | $119 |
| Biopsy of large bowel using a flexible endoscope | 152 | $10,737 | $70 |
| New patient visit (30+ min) | 135 | $9,666 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 103 | $7,965 | $73 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 27 | $4,991 | $185 |
| Long return visit (40+ min) | 24 | $3,505 | $146 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,205 | $189 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 13 | $1,990 | $133 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $1,660 | $128 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 16 | $247 | $14 |
Procedures Medicare counted
| Colonoscopy | 149 | More than 88% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 76 | More than 71% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 183 | 155 | 142 | 178 | 156 | 153 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 139 | 105 | 131 | 150 | 149 | 157 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 142 | 99 | 109 | 109 | 104 | 109 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | – | – | – | 11 | 13 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | – | – | – | 14 | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
659 Original Medicare patients in 2024. Average age 75 · Women 54% · Also on Medicaid 7% · Health risk score 1.03. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 71% · Coronary heart disease 38% · Diabetes 27% · Cancer 17% · Atrial fibrillation 17% · Depression 16% · Chronic kidney disease 14% · Heart failure 11% · COPD 10% · Stroke 8% · Dementia 3%.
The office billed $1,256,835, Medicare allowed $250,318 and paid $189,699; for 2,541 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 659 | 2,541 | 75 | 1.03 | $1,256,835 | $189,699 |
| 2023 | 695 | 2,466 | 75 | 0.94 | $1,201,693 | $193,477 |
| 2022 | 750 | 2,552 | 74 | 1.01 | $906,474 | $211,354 |
| 2021 | 664 | 1,980 | 74 | 0.96 | $575,371 | $172,943 |
| 2020 | 573 | 1,517 | 74 | 1.12 | $475,891 | $132,230 |
| 2019 | 636 | 1,522 | 74 | 1.12 | $409,784 | $149,352 |
| 2018 | 731 | 1,745 | 74 | 1.20 | $457,090 | $164,095 |
| 2017 | 668 | 1,720 | 74 | 1.33 | $440,438 | $155,154 |
| 2016 | 618 | 1,766 | 74 | 1.26 | $437,484 | $158,249 |
| 2015 | 523 | 1,561 | 74 | 1.27 | $384,812 | $142,019 |
| 2014 | 515 | 1,603 | 74 | 1.28 | $393,515 | $147,366 |
| 2013 | 509 | 1,567 | 75 | 1.36 | $473,683 | $148,921 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 148 | $32,322 | $217 |
| Return visit (30+ min) | 236 | $28,563 | $102 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 60 | $26,231 | $40 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 60 | $20,517 | $52 |
| New patient visit (45+ min) | 138 | $17,285 | $125 |
| Short return visit (20+ min) | 172 | $15,589 | $74 |
| New patient visit (30+ min) | 154 | $12,891 | $84 |
| Biopsy of large bowel using a flexible endoscope | 155 | $10,263 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 99 | $7,988 | $77 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $5,567 | $192 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $4,601 | $192 |
| Long return visit (40+ min) | 17 | $2,524 | $148 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,534 | $139 |
2022: 15 services
| Return visit (30+ min) | 258 | $33,678 | $104 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 150 | $32,119 | $214 |
| New patient visit (45+ min) | 213 | $26,862 | $126 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 46 | $23,831 | $42 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 47 | $18,391 | $54 |
| Short return visit (20+ min) | 184 | $17,526 | $72 |
| Biopsy of large bowel using a flexible endoscope | 178 | $11,892 | $67 |
| New patient visit (30+ min) | 121 | $9,455 | $78 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $8,097 | $74 |
| Long return visit (40+ min) | 42 | $6,267 | $149 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $5,807 | $194 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $5,429 | $187 |
| New patient visit (60+ min) | 13 | $2,305 | $177 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 14 | $1,851 | $132 |
| Stool analysis for blood, by peroxidase activity | 53 | $230 | $4 |
2021: 15 services
| Return visit (30+ min) | 246 | $30,609 | $104 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 131 | $28,609 | $218 |
| New patient visit (45+ min) | 205 | $27,524 | $134 |
| Short return visit (20+ min) | 187 | $19,331 | $69 |
| Biopsy of large bowel using a flexible endoscope | 141 | $10,856 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $9,440 | $87 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 34 | $8,855 | $33 |
| New patient visit (30+ min) | 92 | $7,733 | $84 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 33 | $5,699 | $36 |
| Long return visit (40+ min) | 34 | $4,965 | $146 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,617 | $201 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,817 | $201 |
| Short return visit | 22 | $1,159 | $53 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $392 | $26 |
| Stool analysis for blood, by peroxidase activity | 81 | $351 | $4 |
2020: 12 services
| Short return visit (20+ min) | 260 | $26,661 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 105 | $23,149 | $220 |
| Return visit (30+ min) | 195 | $19,876 | $85 |
| New patient visit (45+ min) | 126 | $15,477 | $123 |
| Biopsy of large bowel using a flexible endoscope | 153 | $13,907 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 96 | $8,570 | $87 |
| New patient visit (30+ min) | 64 | $4,230 | $66 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,390 | $199 |
| Long return visit (40+ min) | 26 | $3,044 | $117 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,894 | $207 |
| Short return visit | 50 | $2,350 | $41 |
| Stool analysis for blood, by peroxidase activity | 109 | $467 | $4 |
2019: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 138 | $30,378 | $219 |
| Return visit (30+ min) | 213 | $21,274 | $86 |
| New patient visit (45+ min) | 146 | $18,302 | $125 |
| Biopsy of large bowel using a flexible endoscope | 180 | $15,603 | $85 |
| Short return visit (20+ min) | 163 | $13,175 | $58 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 137 | $12,442 | $88 |
| New patient visit (30+ min) | 148 | $12,041 | $81 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $5,490 | $196 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 23 | $4,366 | $190 |
| Long return visit (40+ min) | 29 | $3,339 | $115 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,718 | $151 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,589 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,428 | $62 |
| Stool analysis for blood, by peroxidase activity | 105 | $444 | $4 |
2018: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 157 | $34,471 | $218 |
| Return visit (30+ min) | 223 | $21,899 | $86 |
| New patient visit (45+ min) | 147 | $18,554 | $126 |
| Biopsy of large bowel using a flexible endoscope | 185 | $14,555 | $78 |
| New patient visit (30+ min) | 180 | $14,170 | $79 |
| Short return visit (20+ min) | 182 | $13,452 | $57 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 138 | $11,986 | $83 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 31 | $6,179 | $199 |
| Long return visit (40+ min) | 52 | $6,029 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,893 | $168 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,752 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $3,034 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,685 | $89 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 13 | $1,621 | $116 |
| Stool analysis for blood, by peroxidase activity | 154 | $644 | $4 |
2017: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 147 | $32,040 | $212 |
| Return visit (30+ min) | 227 | $22,634 | $84 |
| Biopsy of large bowel using a flexible endoscope | 204 | $16,530 | $79 |
| New patient visit (45+ min) | 107 | $12,927 | $121 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 118 | $10,600 | $87 |
| Short return visit (20+ min) | 144 | $10,152 | $57 |
| New patient visit (30+ min) | 136 | $10,076 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,711 | $164 |
| Long return visit (40+ min) | 48 | $5,768 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $5,171 | $59 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,655 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,638 | $87 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $2,952 | $185 |
| Stool analysis for blood, by peroxidase activity | 192 | $887 | $4 |
| New patient visit (15+ min) | 14 | $733 | $52 |
2016: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 121 | $26,168 | $214 |
| Return visit (30+ min) | 206 | $20,902 | $83 |
| Biopsy of large bowel using a flexible endoscope | 168 | $14,429 | $85 |
| New patient visit (45+ min) | 110 | $14,392 | $131 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 144 | $13,383 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $11,736 | $165 |
| New patient visit (30+ min) | 144 | $11,172 | $78 |
| Short return visit (20+ min) | 147 | $10,790 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $8,137 | $61 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 19 | $3,872 | $204 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,177 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,927 | $86 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,306 | $210 |
| Long return visit (40+ min) | 18 | $2,173 | $121 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 13 | $1,985 | $153 |
| Stool analysis for blood, by peroxidase activity | 221 | $1,038 | $4 |
| New patient visit (15+ min) | 16 | $843 | $53 |
2015: 14 services
| Return visit (30+ min) | 217 | $24,249 | $84 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 88 | $22,262 | $250 |
| Biopsy of large bowel using a flexible endoscope | 123 | $14,323 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 124 | $11,227 | $89 |
| New patient visit (45+ min) | 89 | $11,131 | $125 |
| New patient visit (30+ min) | 112 | $8,903 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $8,665 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,282 | $169 |
| Short return visit (20+ min) | 94 | $6,814 | $57 |
| Diagnostic exam of large bowel using a flexible endoscope | 37 | $6,140 | $166 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,780 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,832 | $88 |
| Long return visit (40+ min) | 15 | $1,652 | $110 |
| Stool analysis for blood, by peroxidase activity | 241 | $1,099 | $4 |
2014: 16 services
| Return visit (30+ min) | 171 | $19,584 | $83 |
| Biopsy of large bowel using a flexible endoscope | 128 | $18,537 | $143 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $18,443 | $246 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $12,242 | $60 |
| New patient visit (45+ min) | 91 | $11,152 | $123 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 114 | $10,731 | $93 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 43 | $9,850 | $229 |
| New patient visit (30+ min) | 118 | $9,337 | $79 |
| Short return visit (20+ min) | 100 | $7,179 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $6,996 | $159 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,932 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $3,884 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,275 | $218 |
| Long return visit (40+ min) | 16 | $1,965 | $123 |
| Stool analysis for blood, by peroxidase activity | 230 | $1,045 | $4 |
| Stool analysis for blood to screen for colon tumors | 15 | $49 | $3 |
2013: 15 services
| Biopsy of large bowel using a flexible endoscope | 146 | $23,700 | $156 |
| Return visit (30+ min) | 179 | $21,684 | $83 |
| New patient visit (45+ min) | 126 | $16,193 | $129 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $15,238 | $246 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $11,511 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $11,244 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $9,582 | $160 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 39 | $8,600 | $221 |
| New patient visit (30+ min) | 98 | $8,119 | $83 |
| Short return visit (20+ min) | 76 | $5,089 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $3,282 | $82 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,945 | $227 |
| Long return visit (40+ min) | 21 | $2,312 | $110 |
| Stool analysis for blood, by peroxidase activity | 231 | $1,067 | $4 |
| Stool analysis for blood to screen for colon tumors | 12 | $53 | $4 |
Drugs they prescribed that Part D paid
$760,699
Pharmacies billed $760,699 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 884) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
656 generic and fewer than 11 brand-name prescriptions · $760,699 in drug cost · 55 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 31 | $123,533 | $3,985 |
| Zenpep | 38 | $108,738 | $2,862 |
| Xifaxan | 30 | $72,579 | $2,419 |
| Linzess | 20 | $12,976 | $649 |
| Movantik | 21 | $12,850 | $612 |
See all 20 drugs
| Creon | 31 | $123,533 | $3,985 |
| Zenpep | 38 | $108,738 | $2,862 |
| Xifaxan | 30 | $72,579 | $2,419 |
| Linzess | 20 | $12,976 | $649 |
| Movantik | 21 | $12,850 | $612 |
| Dexlansoprazole Dr | 39 | $10,077 | $258 |
| Mesalamine | 21 | $9,754 | $464 |
| Motegrity | 17 | $8,976 | $528 |
| Balsalazide Disodium | 21 | $7,374 | $351 |
| Pantoprazole | 180 | $3,219 | $18 |
| Omeprazole | 151 | $2,398 | $16 |
| Ursodiol | 16 | $1,782 | $111 |
| Esomeprazole Magnesium | 22 | $1,434 | $65 |
| Lubiprostone | 13 | $1,367 | $105 |
| Budesonide Dr | 17 | $1,085 | $64 |
| Lansoprazole | 20 | $633 | $32 |
| Colestipol | 11 | $629 | $57 |
| Dicyclomine | 19 | $445 | $23 |
| Famotidine | 43 | $442 | $10 |
| Diphenoxylate-Atropine | 12 | $299 | $25 |
Year by year
| 2024 | 884 | 255 | 0% (0) | None | $760,699 |
| 2023 | 960 | 251 | 0% (0) | 24% | $595,391 |
| 2022 | 1,059 | 264 | 0% (0) | None | $933,174 |
| 2021 | 1,002 | 259 | 0% (0) | 29% | $588,872 |
| 2020 | 1,022 | 251 | 0% (0) | None | $439,284 |
| 2019 | 1,012 | 246 | 0% (0) | None | $403,940 |
| 2018 | 1,002 | 226 | 0% (0) | 26% | $270,837 |
| 2017 | 1,111 | 260 | 0% (0) | 27% | $279,815 |
| 2016 | 972 | 221 | 0% (0) | None | $377,435 |
| 2015 | 842 | 190 | 0% (0) | None | $511,072 |
| 2014 | 800 | 221 | 0% (0) | None | $153,773 |
| 2013 | 654 | 211 | None | 59% | $130,242 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Creon | 55 | $198,558 | $3,610 |
| Zenpep | 27 | $66,210 | $2,452 |
| Xifaxan | 20 | $58,210 | $2,910 |
| Mesalamine | 29 | $27,164 | $937 |
| Linzess | 20 | $14,610 | $730 |
| Dexlansoprazole Dr | 41 | $14,361 | $350 |
| Movantik | 13 | $7,199 | $554 |
| Motegrity | 12 | $6,523 | $544 |
| Balsalazide Disodium | 26 | $6,003 | $231 |
| Ursodiol | 26 | $5,394 | $207 |
| Pantoprazole | 173 | $4,049 | $23 |
| Lubiprostone | 15 | $3,230 | $215 |
| Esomeprazole Magnesium | 34 | $3,225 | $95 |
| Budesonide Ec | 12 | $2,923 | $244 |
| Omeprazole | 183 | $2,632 | $14 |
| Lansoprazole | 42 | $1,574 | $37 |
| Colestipol | 18 | $1,295 | $72 |
| Dicyclomine | 22 | $719 | $33 |
| Famotidine | 44 | $690 | $16 |
| Diphenoxylate-Atropine | 13 | $495 | $38 |
2022: 23 drugs
| Stelara | 11 | $284,126 | $25,830 |
| Creon | 52 | $192,156 | $3,695 |
| Ocaliva | 12 | $93,426 | $7,785 |
| Zenpep | 16 | $73,001 | $4,563 |
| Xifaxan | 23 | $55,513 | $2,414 |
| Mesalamine | 33 | $23,730 | $719 |
| Dexilant | 41 | $20,781 | $507 |
| Vemlidy | 11 | $15,417 | $1,402 |
| Motegrity | 20 | $10,430 | $521 |
| Budesonide Ec | 20 | $6,180 | $309 |
| Ursodiol | 22 | $5,633 | $256 |
| Lubiprostone | 17 | $5,492 | $323 |
| Balsalazide Disodium | 18 | $4,533 | $252 |
| Lansoprazole | 51 | $4,116 | $81 |
| Pantoprazole | 161 | $3,188 | $20 |
| Omeprazole | 205 | $2,748 | $13 |
| Esomeprazole Magnesium | 26 | $1,379 | $53 |
| Colestipol | 14 | $1,282 | $92 |
| Sucralfate | 28 | $998 | $36 |
| Famotidine | 50 | $564 | $11 |
| Dicyclomine | 24 | $551 | $23 |
| Diphenoxylate-Atropine | 12 | $490 | $41 |
| Metronidazole | 13 | $169 | $13 |
2021: 21 drugs
| Creon | 43 | $119,797 | $2,786 |
| Zenpep | 25 | $113,608 | $4,544 |
| Xifaxan | 22 | $50,506 | $2,296 |
| Mesalamine | 38 | $28,701 | $755 |
| Dexilant | 32 | $17,459 | $546 |
| Vemlidy | 13 | $16,774 | $1,290 |
| Linzess | 20 | $12,707 | $635 |
| Motegrity | 22 | $10,734 | $488 |
| Trulance | 18 | $9,698 | $539 |
| Amitiza | 17 | $9,062 | $533 |
| Budesonide Ec | 15 | $5,898 | $393 |
| Mesalamine Dr | 11 | $4,711 | $428 |
| Ursodiol | 17 | $4,386 | $258 |
| Esomeprazole Magnesium | 22 | $3,372 | $153 |
| Pantoprazole | 169 | $2,833 | $17 |
| Omeprazole | 192 | $2,533 | $13 |
| Clenpiq | 14 | $2,135 | $152 |
| Lansoprazole | 35 | $1,822 | $52 |
| Sucralfate | 21 | $1,816 | $86 |
| Famotidine | 59 | $1,032 | $17 |
| Dicyclomine | 29 | $902 | $31 |
2020: 23 drugs
| Creon | 61 | $140,672 | $2,306 |
| Zenpep | 29 | $62,215 | $2,145 |
| Xifaxan | 20 | $43,560 | $2,178 |
| Mesalamine | 43 | $31,243 | $727 |
| Pentasa | 13 | $25,284 | $1,945 |
| Budesonide Ec | 22 | $15,770 | $717 |
| Vemlidy | 12 | $14,718 | $1,227 |
| Amitiza | 32 | $13,150 | $411 |
| Dexilant | 24 | $10,720 | $447 |
| Trulance | 20 | $10,609 | $530 |
| Linzess | 21 | $9,487 | $452 |
| Ursodiol | 15 | $4,784 | $319 |
| Mercaptopurine | 22 | $4,030 | $183 |
| Esomeprazole Magnesium | 35 | $3,854 | $110 |
| Omeprazole | 221 | $2,928 | $13 |
| Pantoprazole | 130 | $1,708 | $13 |
| Sucralfate | 31 | $1,638 | $53 |
| Colestipol | 19 | $1,410 | $74 |
| Lansoprazole | 40 | $1,313 | $33 |
| Famotidine | 46 | $789 | $17 |
| Dicyclomine | 18 | $486 | $27 |
| Ondansetron | 16 | $293 | $18 |
| Metronidazole | 13 | $154 | $12 |
2019: 22 drugs
| Creon | 35 | $75,477 | $2,156 |
| Pentasa | 15 | $28,452 | $1,897 |
| Budesonide Ec | 37 | $27,434 | $741 |
| Xifaxan | 12 | $17,955 | $1,496 |
| Linzess | 33 | $16,611 | $503 |
| Mesalamine | 18 | $15,672 | $871 |
| Amitiza | 30 | $14,492 | $483 |
| Trulance | 23 | $11,116 | $483 |
| Dexilant | 23 | $8,772 | $381 |
| Ursodiol | 15 | $7,230 | $482 |
| Mercaptopurine | 23 | $6,554 | $285 |
| Omeprazole | 302 | $4,994 | $17 |
| Erythromycin Ethylsuccinate | 15 | $4,293 | $286 |
| Pantoprazole | 94 | $2,347 | $25 |
| Colestipol | 23 | $1,782 | $77 |
| Esomeprazole Magnesium | 35 | $1,676 | $48 |
| Lansoprazole | 37 | $1,525 | $41 |
| Sucralfate | 19 | $675 | $36 |
| Dicyclomine | 22 | $374 | $17 |
| Ondansetron | 21 | $315 | $15 |
| Famotidine | 17 | $230 | $14 |
| Ranitidine | 17 | $195 | $11 |
2018: 23 drugs
| Pentasa | 14 | $28,889 | $2,064 |
| Mesalamine | 22 | $24,788 | $1,127 |
| Linzess | 42 | $17,011 | $405 |
| Budesonide Ec | 21 | $17,008 | $810 |
| Xifaxan | 11 | $16,298 | $1,482 |
| Zenpep | 12 | $15,193 | $1,266 |
| Amitiza | 35 | $14,297 | $408 |
| Vemlidy | 11 | $11,381 | $1,035 |
| Dexilant | 22 | $10,714 | $487 |
| Ursodiol | 18 | $10,123 | $562 |
| Mercaptopurine | 38 | $7,984 | $210 |
| Delzicol | 12 | $7,426 | $619 |
| Omeprazole | 341 | $4,285 | $13 |
| Esomeprazole Magnesium | 35 | $3,030 | $87 |
| Lansoprazole | 35 | $2,208 | $63 |
| Colestipol | 38 | $2,150 | $57 |
| Pantoprazole | 65 | $1,400 | $22 |
| Sucralfate | 27 | $816 | $30 |
| Ondansetron | 21 | $405 | $19 |
| Polyethylene Glycol 3350 | 18 | $369 | $20 |
| Ranitidine | 22 | $263 | $12 |
| Dicyclomine | 17 | $226 | $13 |
| Famotidine | 11 | $163 | $15 |
2017: 23 drugs
| Creon | 11 | $32,455 | $2,950 |
| Lialda | 15 | $25,733 | $1,716 |
| Xifaxan | 18 | $21,552 | $1,197 |
| Amitiza | 32 | $11,996 | $375 |
| Budesonide Ec | 18 | $11,667 | $648 |
| Linzess | 32 | $11,370 | $355 |
| Mesalamine | 11 | $10,874 | $989 |
| Mercaptopurine | 48 | $8,778 | $183 |
| Dexilant | 26 | $8,741 | $336 |
| Nexium | 13 | $7,116 | $547 |
| Esomeprazole Magnesium | 49 | $6,819 | $139 |
| Delzicol | 11 | $6,265 | $570 |
| Omeprazole | 362 | $4,602 | $13 |
| Ursodiol | 12 | $3,827 | $319 |
| Suprep | 37 | $3,215 | $87 |
| Balsalazide Disodium | 17 | $2,487 | $146 |
| Pantoprazole | 101 | $1,975 | $20 |
| Colestipol | 27 | $1,697 | $63 |
| Lansoprazole | 28 | $1,053 | $38 |
| Polyethylene Glycol 3350 | 25 | $645 | $26 |
| Sulfasalazine | 20 | $639 | $32 |
| Ranitidine | 45 | $377 | $8 |
| Famotidine | 21 | $149 | $7 |
2016: 19 drugs
| Lialda | 21 | $28,618 | $1,363 |
| Amitiza | 60 | $19,487 | $325 |
| Xifaxan | 19 | $18,811 | $990 |
| Asacol Hd | 13 | $18,141 | $1,395 |
| Budesonide Ec | 17 | $17,459 | $1,027 |
| Nexium | 19 | $13,413 | $706 |
| Esomeprazole Magnesium | 31 | $11,766 | $380 |
| Linzess | 19 | $7,316 | $385 |
| Dexilant | 26 | $6,795 | $261 |
| Mercaptopurine | 64 | $5,411 | $85 |
| Omeprazole | 270 | $4,465 | $17 |
| Suprep | 48 | $3,984 | $83 |
| Balsalazide Disodium | 20 | $2,962 | $148 |
| Pantoprazole | 84 | $1,742 | $21 |
| Lansoprazole | 23 | $1,150 | $50 |
| Polyethylene Glycol 3350 | 24 | $614 | $26 |
| Ranitidine | 50 | $564 | $11 |
| Famotidine | 20 | $107 | $5 |
| Amitriptyline | 13 | $75 | $6 |
2015: 18 drugs
| Amitiza | 51 | $16,075 | $315 |
| Budesonide Ec | 15 | $15,413 | $1,028 |
| Nexium | 22 | $11,499 | $523 |
| Apriso | 14 | $9,799 | $700 |
| Ursodiol | 18 | $7,704 | $428 |
| Mercaptopurine | 59 | $5,880 | $100 |
| Dexilant | 24 | $5,264 | $219 |
| Suprep | 49 | $3,938 | $80 |
| Balsalazide Disodium | 16 | $2,296 | $144 |
| Omeprazole | 171 | $2,054 | $12 |
| Pantoprazole | 83 | $1,247 | $15 |
| Lansoprazole | 23 | $1,107 | $48 |
| Rabeprazole | 13 | $1,063 | $82 |
| Colestipol | 11 | $935 | $85 |
| Polyethylene Glycol 3350 | 32 | $857 | $27 |
| Ranitidine | 38 | $463 | $12 |
| Sucralfate | 13 | $386 | $30 |
| Famotidine | 13 | $84 | $6 |
2014: 19 drugs
| Nexium | 44 | $23,767 | $540 |
| Budesonide Ec | 19 | $19,312 | $1,016 |
| Asacol Hd | 16 | $15,985 | $999 |
| Apriso | 28 | $13,162 | $470 |
| Lialda | 15 | $11,276 | $752 |
| Amitiza | 33 | $9,859 | $299 |
| Suprep | 113 | $8,709 | $77 |
| Ursodiol | 21 | $5,450 | $260 |
| Dexilant | 29 | $5,374 | $185 |
| Prevacid | 11 | $3,630 | $330 |
| Omeprazole | 159 | $2,634 | $17 |
| Mercaptopurine | 45 | $2,462 | $55 |
| Rabeprazole | 12 | $1,202 | $100 |
| Lansoprazole | 21 | $1,146 | $55 |
| Pantoprazole | 51 | $1,064 | $21 |
| Ranitidine | 39 | $766 | $20 |
| Sucralfate | 12 | $689 | $57 |
| Polyethylene Glycol 3350 | 16 | $477 | $30 |
| Fluoxetine | 11 | $67 | $6 |
2013: 15 drugs
| Nexium | 75 | $29,355 | $391 |
| Asacol Hd | 17 | $16,470 | $969 |
| Suprep | 130 | $9,433 | $73 |
| Apriso | 20 | $8,827 | $441 |
| Amitiza | 16 | $4,284 | $268 |
| Dexilant | 24 | $3,789 | $158 |
| Omeprazole | 75 | $1,887 | $25 |
| Ursodiol | 24 | $1,788 | $74 |
| Lansoprazole | 18 | $1,603 | $89 |
| Mercaptopurine | 21 | $1,576 | $75 |
| Pantoprazole | 37 | $807 | $22 |
| Ranitidine | 34 | $541 | $16 |
| Polyethylene Glycol 3350 | 18 | $522 | $29 |
| Fluoxetine | 12 | $64 | $5 |
| Amitriptyline | 11 | $48 | $4 |
Money from drug and device companies
$1,862 in 2025
| 2025 | 11 | 65 | None | $1,862 |
| 2024 | 12 | 40 | None | $1,146 |
| 2023 | 16 | 42 | None | $1,205 |
| 2022 | 12 | 80 | None | $1,610 |
| 2021 | 13 | 89 | None | $1,527 |
| 2020 | 13 | 42 | $400 | $1,311 |
| 2019 | 12 | 52 | $42 | $1,021 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Xeljanz | $289 | 10 payments
|
| Abbvie | Skyrizi | $284 | 10 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $271 | 7 payments
|
| Genzyme | Dupixent | $251 | 5 payments
|
| Janssen Biotech | Tremfya | $225 | 12 payments
|
| Aimmune Therapeutics | Vowst | $189 | 8 payments
|
See all 65 published payments
| Abbvie | Meals · 2025-12-15 | Skyrizi | $32 |
| Janssen Biotech | Meals · 2025-12-08 | Tremfya | $29 |
| Aimmune Therapeutics | Meals · 2025-12-04 | Zenpep | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-01 | Entyvio | $30 |
| Genzyme | Meals · 2025-11-24 | Dupixent | $49 |
| Janssen Biotech | Meals · 2025-11-21 | Tremfya | $25 |
| Madrigal Pharmaceuticals | Meals · 2025-11-20 | Rezdiffra | $35 |
| Abbvie | Meals · 2025-11-17 | Skyrizi | $28 |
| Pfizer | Meals · 2025-11-10 | Velsipity | $22 |
| Aimmune Therapeutics | Meals · 2025-10-30 | Vowst | $32 |
| Abbvie | Meals · 2025-10-29 | Creon | $7 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-27 | Entyvio | $30 |
| Ardelyx | Meals · 2025-10-23 | Ibsrela | $20 |
| Janssen Biotech | Meals · 2025-10-16 | Tremfya | $7 |
| Novo Nordisk | Meals · 2025-10-16 | Wegovy | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-10-16 | Dupixent | $9 |
| Madrigal Pharmaceuticals | Meals · 2025-10-13 | Rezdiffra | $34 |
| Janssen Biotech | Meals · 2025-10-11 | Tremfya | $12 |
| Pfizer | Meals · 2025-10-06 | Xeljanz | $27 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-29 | Relistor | $22 |
| Janssen Biotech | Meals · 2025-09-22 | Tremfya | $23 |
| Pfizer | Meals · 2025-09-04 | Velsipity | $120 |
| Genzyme | Meals · 2025-09-04 | Dupixent | $36 |
| Abbvie | Meals · 2025-08-25 | Rinvoq | $18 |
| Aimmune Therapeutics | Meals · 2025-08-21 | Vowst | $33 |
| Pfizer | Meals · 2025-08-18 | Xeljanz | $28 |
| Abbvie | Meals · 2025-08-14 | Rinvoq | $4 |
| Abbvie | Meals · 2025-08-11 | Linzess | $25 |
| Ardelyx | Meals · 2025-08-07 | Ibsrela | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-07-25 | Dupixent | $33 |
| Aimmune Therapeutics | Meals · 2025-07-24 | Vowst | $4 |
| Janssen Biotech | Meals · 2025-07-21 | Tremfya | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-17 | Entyvio | $24 |
| Genzyme | Meals · 2025-06-26 | Dupixent | $121 |
| Ardelyx | Meals · 2025-06-26 | Ibsrela | $25 |
| Janssen Biotech | Meals · 2025-06-25 | Tremfya | $24 |
| Pfizer | Meals · 2025-06-23 | Xeljanz | $18 |
| Janssen Biotech | Meals · 2025-06-16 | Tremfya | $20 |
| Madrigal Pharmaceuticals | Meals · 2025-06-12 | Rezdiffra | $9 |
| Madrigal Pharmaceuticals | Meals · 2025-06-11 | Rezdiffra | $118 |
| Genzyme | Meals · 2025-06-09 | Dupixent | $34 |
| Madrigal Pharmaceuticals | Meals · 2025-06-03 | Rezdiffra | $7 |
| Aimmune Therapeutics | Meals · 2025-05-22 | Vowst | $29 |
| Janssen Biotech | Meals · 2025-05-19 | Tremfya | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-05-15 | Dupixent | $37 |
| Abbvie | Meals · 2025-05-12 | Rinvoq | $21 |
| Pfizer | Meals · 2025-05-05 | Xeljanz | $4 |
| Abbvie | Meals · 2025-05-01 | Skyrizi | $104 |
| Pfizer | Meals · 2025-04-28 | Xeljanz | $27 |
| Abbvie | Meals · 2025-04-21 | Rinvoq | $35 |
| Janssen Biotech | Meals · 2025-04-17 | Tremfya | $21 |
| Aimmune Therapeutics | Meals · 2025-04-03 | Vowst | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-03-27 | Dupixent | $37 |
| Janssen Biotech | Meals · 2025-03-24 | Tremfya | $10 |
| Aimmune Therapeutics | Meals · 2025-03-10 | Zenpep | $24 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $7 |
| Madrigal Pharmaceuticals | Meals · 2025-03-06 | Rezdiffra | $36 |
| Genzyme | Meals · 2025-02-26 | Dupixent | $11 |
| Pfizer | Meals · 2025-02-24 | Xeljanz | $17 |
| Pfizer | Meals · 2025-02-24 | Xeljanz | $3 |
| Madrigal Pharmaceuticals | Meals · 2025-02-03 | Rezdiffra | $32 |
| Abbvie | Meals · 2025-01-29 | Rinvoq | $10 |
| Pfizer | Meals · 2025-01-23 | Xeljanz | $23 |
| Aimmune Therapeutics | Meals · 2025-01-16 | Vowst | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-01-13 | Dupixent | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,146
| Abbvie | Rinvoq | $262 | 10 payments
|
| Janssen Biotech | Tremfya | $213 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Zeposia | $122 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $104 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $95 | 3 payments
|
| Pfizer | Xeljanz | $85 | 4 payments
|
| Genzyme | Dupixent | $72 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $61 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Eohilia | $48 | 2 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $35 | 1 payment
|
| Lilly USA | Omvoh | $26 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $22 | 1 payment
|
2023: $1,205
| Janssen Biotech | Stelara | $224 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $210 | 4 payments
|
| AbbVie | Skyrizi | $184 | 4 payments
|
| Pfizer | Xeljanz | $145 | 8 payments
|
| Genzyme | Dupixent | $85 | 3 payments
|
| RedHill Biopharma | Talicia | $57 | 3 payments
|
| Gilead Sciences | None | $49 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $46 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $37 | 2 payments
|
| Braintree Laboratories | Sutab | $37 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $33 | 1 payment
|
| CapsoVision | Capsocam Plus | $22 | 1 payment
|
| Nestle Healthcare Nutrition | Zenpep | $22 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $21 | 1 payment
|
| Vibrant Gastro | Vibrant Starter Kit | $19 | 1 payment
|
| Celgene | Zeposia | $13 | 1 payment
|
2022: $1,610
| Abbvie | Linzess | $336 | 14 payments
|
| Celgene | Zeposia | $235 | 14 payments
|
| Janssen Biotech | Stelara | $215 | 17 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $177 | 11 payments
|
| Pfizer | Xeljanz | $136 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $130 | 1 payment
|
| Gilead Sciences | None | $118 | 6 payments
|
| Nestle HealthCare Nutrition | Zenpep | $82 | 4 payments
|
| Genzyme | Dupixent | $66 | 2 payments
|
| RedHill Biopharma | Talicia | $50 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $46 | 2 payments
|
| Ardelyx | Ibsrela | $19 | 1 payment
|
2021: $1,527
| Gilead Sciences | Vemlidy | $345 | 19 payments
|
| AbbVie | Linzess | $196 | 13 payments
|
| Janssen Biotech | Stelara | $193 | 12 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $180 | 17 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $157 | 10 payments
|
| Nestle HealthCare Nutrition | Zenpep | $114 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Zeposia | $112 | 1 payment
|
| Celgene | Zeposia | $102 | 5 payments
|
| Intercept Pharmaceuticals | Ocaliva | $42 | 2 payments
|
| Boston Scientific | General Polypectomy | $24 | 1 payment
|
| RedHill Biopharma | Talicia | $22 | 1 payment
|
| QOL Medical | Sucraid | $21 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $20 | 1 payment
|
2020: $1,311
| QOL Medical | Sucraid | $400 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $211 | 16 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $145 | 1 payment
|
| Janssen Biotech | Stelara | $123 | 7 payments
|
| Janssen Scientific Affairs | Stelara | $95 | 1 payment
|
| AbbVie | Humira | $84 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $68 | 3 payments
|
| RedHill Biopharma | Talicia | $67 | 3 payments
|
| Merck Sharp & Dohme | Dificid | $42 | 2 payments
|
| Gilead Sciences | None | $33 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $17 | 1 payment
|
| Pfizer | Xeljanz | $15 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $13 | 1 payment
|
2019: $1,021
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $216 | 16 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $170 | 8 payments
|
| Pfizer | Xeljanz | $147 | 6 payments
|
| Janssen Biotech | Stelara | $113 | 8 payments
|
| Romark Laboratories LC | Alinia | $102 | 2 payments
|
| Gilead Sciences | None | $74 | 3 payments
|
| AbbVie | Creon | $67 | 3 payments
|
| Intercept Pharmaceuticals | Ocaliva | $42 | 2 payments
|
| Concordia Pharmaceuticals | Donnatal | $29 | 1 payment
|
| Daiichi Sankyo | Injectafer | $23 | 1 payment
|
| Shionogi | Mulpleta | $20 | 1 payment
|
| Allergan | Viberzi | $17 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| UCB Biosciences Inc. · A Non-Interventional, Long Term, Post-Marketing Registry of Patients Treated With Certolizumab Pegol Cimzia for Crohn'S Disease · 2020 | This clinician | $4,000 |
| UCB Biosciences Inc. · A Non-Interventional, Long Term, Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia) for Crohn'S Disease · 2019 | This clinician | $2,000 |
| UCB Biosciences Inc. · A Non-Interventional, Long Term, Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia) for Crohn'S Disease · 2021 | This clinician | $400 |
Checkups this office reported
2 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 90.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Patients can see their records onlinePatients who were given electronic access to their health information | 92%That's most of the people this applied to. | 296 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 41%That's less than half. | 241 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Chronic Care and Preventative Care Management for Empaneled Patients
- Did a security review of patient data
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Implementation of formal quality improvement methods, practice changes, or other practice improvement processes
- Implementation of medication management practice improvements
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Use of QCDR data for ongoing practice assessment and improvements
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1346200730
- Licence
- CA G44883California G44883: Current · expires 2028-09-30
- Trained
- Js Weill Medical College, Cornell University, 1978 · 48 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 16311 Ventura Blvd, Suite 775, Encino, CA, 91436
- NPI first listed
- 2006-03-28
- NPI last updated
- 2015-03-24
This is when the NPI record was last certified, not a medical board exam.